LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.

    Vergori, Alessandra / Pianura, Elisa / Lorenzini, Patrizia / D'Abramo, Alessandra / Di Stefano, Federica / Grisetti, Susanna / Vita, Serena / Pinnetti, Carmela / Donno, Davide Roberto / Marini, Maria Cristina / Nicastri, Emanuele / Ianniello, Stefania / Antinori, Andrea

    Annals of medicine

    2021  Volume 53, Issue 1, Page(s) 295–301

    Abstract: ... complicated by Ilio-psoas haematomas (IPHs) at our COVID-Hospital in Rome, Italy.: Results: Over ... complication in COVID-19 inpatients. KEY MESSAGE Critically ill patients with COVID-19 are at increased risk ... of hypercoagulability state and anticoagulation therapy is recommended. Ilio-psoas haematoma (IPH) is found to be ...

    Abstract Introduction: Critically ill patients with COVID-19 are at increased risk of developing a hypercoagulable state due to haemostatic changes directly related to the SARS-CoV-2 infection or to the consequence of the cytokine storm. Anticoagulation is now recommended to reduce the thrombotic risk. Ilio-psoas haematoma (IPH) is a potentially lethal condition that can arise during the hospitalization, especially in intensive care units (ICUs) and frequently reported as a complication of anticoagulation treatment.
    Materials and methods: We report a case series of seven subjects with SARS-CoV-2 pneumonia complicated by Ilio-psoas haematomas (IPHs) at our COVID-Hospital in Rome, Italy.
    Results: Over the observation period, 925 subjects with confirmed SARS-CoV-2 infection were admitted to our COVID-hospital. Among them, we found seven spontaneous IPHs with an incidence of 7.6 cases per 1000 hospitalization. All the reported cases had a severe manifestation of COVID-19 pneumonia, with at least one comorbidity and 5/7 were on treatment with low weight molecular heparin for micro or macro pulmonary thrombosis.
    Conclusions: Given the indications to prescribe anticoagulant therapy in COVID-19 and the lack of solid evidences on the optimal dose and duration, it is important to be aware of the iliopsoas haematoma as a potentially serious complication in COVID-19 inpatients. KEY MESSAGE Critically ill patients with COVID-19 are at increased risk of hypercoagulability state and anticoagulation therapy is recommended. Ilio-psoas haematoma (IPH) is found to be a complication of anticoagulation regimen especially in severe COVID-19 cases. An incidence of 7.6 cases per 1000 admission of IPHs was reported. Hypoesthesia of the lower limbs, pain triggered by femoral rotation, hypovolaemia and anaemia are the most common symptoms and signs of IPHs that should alert physician.
    MeSH term(s) Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/virology ; Critical Illness/mortality ; Critical Illness/therapy ; Female ; Glucocorticoids/therapeutic use ; Hematoma/chemically induced ; Hematoma/diagnosis ; Hematoma/drug therapy ; Hematoma/epidemiology ; Heparin, Low-Molecular-Weight ; Hospital Mortality ; Humans ; Incidence ; Intensive Care Units ; Italy/epidemiology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Muscular Diseases ; Psoas Muscles/diagnostic imaging ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/pathogenicity ; Severity of Illness Index ; Thrombophilia/drug therapy ; Thrombophilia/etiology ; Tomography, X-Ray Computed ; Treatment Outcome ; COVID-19 Drug Treatment
    Chemical Substances Anticoagulants ; Glucocorticoids ; Heparin, Low-Molecular-Weight
    Language English
    Publishing date 2021-01-24
    Publishing country England
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1004226-x
    ISSN 1365-2060 ; 1651-2219 ; 0785-3890 ; 1743-1387
    ISSN (online) 1365-2060 ; 1651-2219
    ISSN 0785-3890 ; 1743-1387
    DOI 10.1080/07853890.2021.1875498
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Spontaneous ilio-psoas haematomas (IPHs)

    Alessandra Vergori / Elisa Pianura / Patrizia Lorenzini / Alessandra D’Abramo / Federica Di Stefano / Susanna Grisetti / Serena Vita / Carmela Pinnetti / Davide Roberto Donno / Maria Cristina Marini / Emanuele Nicastri / Stefania Ianniello / Andrea Antinori

    Annals of Medicine, Vol 53, Iss 1, Pp 295-

    a warning for COVID-19 inpatients

    2021  Volume 301

    Abstract: ... complicated by Ilio-psoas haematomas (IPHs) at our COVID-Hospital in Rome, Italy.Results Over the observation ... complication in COVID-19 inpatients.KEY MESSAGECritically ill patients with COVID-19 are at increased risk ... of hypercoagulability state and anticoagulation therapy is recommended.Ilio-psoas haematoma (IPH) is found to be ...

    Abstract AbstractIntroduction Critically ill patients with COVID-19 are at increased risk of developing a hypercoagulable state due to haemostatic changes directly related to the SARS-CoV-2 infection or to the consequence of the cytokine storm. Anticoagulation is now recommended to reduce the thrombotic risk. Ilio-psoas haematoma (IPH) is a potentially lethal condition that can arise during the hospitalization, especially in intensive care units (ICUs) and frequently reported as a complication of anticoagulation treatment.Materials and methods We report a case series of seven subjects with SARS-CoV-2 pneumonia complicated by Ilio-psoas haematomas (IPHs) at our COVID-Hospital in Rome, Italy.Results Over the observation period, 925 subjects with confirmed SARS-CoV-2 infection were admitted to our COVID-hospital. Among them, we found seven spontaneous IPHs with an incidence of 7.6 cases per 1000 hospitalization. All the reported cases had a severe manifestation of COVID-19 pneumonia, with at least one comorbidity and 5/7 were on treatment with low weight molecular heparin for micro or macro pulmonary thrombosis.Conclusions Given the indications to prescribe anticoagulant therapy in COVID-19 and the lack of solid evidences on the optimal dose and duration, it is important to be aware of the iliopsoas haematoma as a potentially serious complication in COVID-19 inpatients.KEY MESSAGECritically ill patients with COVID-19 are at increased risk of hypercoagulability state and anticoagulation therapy is recommended.Ilio-psoas haematoma (IPH) is found to be a complication of anticoagulation regimen especially in severe COVID-19 cases.An incidence of 7.6 cases per 1000 admission of IPHs was reported.Hypoesthesia of the lower limbs, pain triggered by femoral rotation, hypovolaemia and anaemia are the most common symptoms and signs of IPHs that should alert physician.
    Keywords Ilio-psoas haematoma ; heparin ; COVID-19 ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Taylor & Francis Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top